Bridgette Kunst
Bridgette Kunst MA RAC is Managing Director of Bridge Regulatory Affairs, LLC
JournalMapping early and often FDA interaction in rare disease programmes: Building the path from discovery to registration
This article explores the challenges unique to rare disease development and presents an overview of key FDA interaction opportunities and regulatory advancements